DE602006013143D1 - Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate - Google Patents

Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate

Info

Publication number
DE602006013143D1
DE602006013143D1 DE602006013143T DE602006013143T DE602006013143D1 DE 602006013143 D1 DE602006013143 D1 DE 602006013143D1 DE 602006013143 T DE602006013143 T DE 602006013143T DE 602006013143 T DE602006013143 T DE 602006013143T DE 602006013143 D1 DE602006013143 D1 DE 602006013143D1
Authority
DE
Germany
Prior art keywords
capturing
protein forms
circulating protein
forms
aggregate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006013143T
Other languages
English (en)
Inventor
Anne Eveno-Nobile
Anthony William Coleman
Sebastien Cecillon
Herve Perron
Marc Rodrigue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Centre National de la Recherche Scientifique CNRS
Universite Claude Bernard Lyon 1 UCBL
Original Assignee
Biomerieux SA
Centre National de la Recherche Scientifique CNRS
Universite Claude Bernard Lyon 1 UCBL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA, Centre National de la Recherche Scientifique CNRS, Universite Claude Bernard Lyon 1 UCBL filed Critical Biomerieux SA
Publication of DE602006013143D1 publication Critical patent/DE602006013143D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE602006013143T 2005-07-21 2006-07-07 Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate Active DE602006013143D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507757A FR2888937B1 (fr) 2005-07-21 2005-07-21 Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes
PCT/FR2006/001641 WO2007010110A2 (fr) 2005-07-21 2006-07-07 Procede de detection des fpca utilisant un agent d'agregation des fpca et un agent de capture des agregats formes

Publications (1)

Publication Number Publication Date
DE602006013143D1 true DE602006013143D1 (de) 2010-05-06

Family

ID=36011928

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006013143T Active DE602006013143D1 (de) 2005-07-21 2006-07-07 Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate

Country Status (8)

Country Link
US (1) US8158441B2 (de)
EP (1) EP1907861B1 (de)
JP (2) JP5693816B2 (de)
AT (1) ATE462140T1 (de)
DE (1) DE602006013143D1 (de)
ES (1) ES2343474T3 (de)
FR (1) FR2888937B1 (de)
WO (1) WO2007010110A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2931695B1 (fr) * 2008-05-28 2010-06-25 Centre Nat Rech Scient Procede d'extraction selective de proteines membranaires avec les calixarenes
JP5732292B2 (ja) 2011-03-28 2015-06-10 日東電工株式会社 スルホン酸基含有ジアミン化合物とその製造方法
WO2013091074A1 (en) * 2011-12-21 2013-06-27 Uvic Industry Partnerships Inc. Method and array for identifying histone-code-related analytes
KR101658620B1 (ko) * 2014-12-02 2016-09-23 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
US10338037B2 (en) 2015-08-18 2019-07-02 Uvic Industry Partnerships Inc. Compounds and conjugates for identifying and separating post-translationally modified analytes
ES2804541T3 (es) * 2015-11-30 2021-02-08 Univ Wien Compuesto para su uso en la prevención y el tratamiento de enfermedades neurodegenerativas
EP3207925A1 (de) * 2016-02-22 2017-08-23 Universität Wien Zusammensetzung zur verwendung bei der vorbeugung und behandlung neurodegenerativer erkrankungen
US11415574B2 (en) * 2017-03-31 2022-08-16 NeuroDiagnostics LLC Lymphocyte-based morphometric test for alzheimer's disease
CA3084887A1 (en) 2019-06-25 2020-12-25 Uvic Industry Partnerships Inc. Compound and dimer complex embodiments for supramolecular sensing
CN111517947B (zh) * 2020-03-18 2022-05-24 西北师范大学 一种基于功能化的双边柱[5]芳烃传感器分子及其合成和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365414B1 (en) * 1994-08-26 2002-04-02 The General Hospital Corporation Vitro system for determining formation of Aβ amyloid
US5639626A (en) 1994-11-15 1997-06-17 Chiron Diagnostics Corporation Reagents for specific binding assays
WO1997041856A1 (en) * 1996-05-08 1997-11-13 Massachusetts Institute Of Technology ORGANOMETALLIC LIGANDS FOR THE LOCALIZATION AND QUANTIFICATION OF AMYLOID IN VIVO AND $i(IN VITRO)
GB9610829D0 (en) * 1996-05-23 1996-07-31 Medical Res Council Screening of agents for treatment of azlheimers disease
CA2301142A1 (en) * 1997-08-14 1999-02-25 The Regents Of The University Of California Fluorescent amyloid a.beta. peptides and uses thereof
MY128673A (en) * 1997-10-30 2007-02-28 Shell Int Research Catalytic hydrolysis of alkylene oxides
GB9908059D0 (en) * 1999-04-09 1999-06-02 Imp College Innovations Ltd Diagnosis and treatment of diseases
AU2002241909A1 (en) * 2001-01-19 2002-07-30 Baxter Healthcare S.A. Method of detecting prp protein and kits therefor
DE10107083C2 (de) 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
DE10119713A1 (de) 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
RU2309410C2 (ru) * 2002-02-28 2007-10-27 Майкроусенс Байофейдж Лимитед Связывание патологических форм прионовых белков
WO2004041779A2 (en) * 2002-11-01 2004-05-21 Proteotech, Inc. Amyloid plaque formation by glycosaminoglycans
FR2849205B1 (fr) * 2002-12-20 2005-02-11 Afssa Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification
FR2849204B1 (fr) * 2002-12-20 2005-02-11 Afssa Procede de detection de la prpsc utilisant un antibiotique d de la famille des aminoglycosides pour l'elimination et la detection de la prpsc dans des echantillons biologiques
IL158010A0 (en) 2003-09-18 2004-03-28 Hadasit Med Res Service Methods and kits for the detection of prion diseases
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique

Also Published As

Publication number Publication date
ATE462140T1 (de) 2010-04-15
JP2009501922A (ja) 2009-01-22
FR2888937A1 (fr) 2007-01-26
US8158441B2 (en) 2012-04-17
JP2014178337A (ja) 2014-09-25
JP5693816B2 (ja) 2015-04-01
FR2888937B1 (fr) 2012-10-26
JP5785642B2 (ja) 2015-09-30
ES2343474T3 (es) 2010-08-02
WO2007010110A2 (fr) 2007-01-25
EP1907861A2 (de) 2008-04-09
US20100062540A1 (en) 2010-03-11
EP1907861B1 (de) 2010-03-24
WO2007010110A3 (fr) 2007-04-05

Similar Documents

Publication Publication Date Title
DE602006013143D1 (de) Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate
NO20072721L (no) Polypeptides that bind BR3 and uses thereof
DE602005021485D1 (de) Verfahren und zusammensetzungen mit molkeproteinisolaten
DE602006007808D1 (de) Vorrichtung, verfahren und verwendung zur behandlung von neuropathie mit stickoxid
DE602004006894D1 (de) Vorrichtung zur klassifizierung von sitzbelegung
PL1883474T3 (pl) System do zintegrowanej i zautomatyzowanej analizy dna lub białka oraz sposób działania takiego systemu
DE602005024639D1 (de) Verfahren und Gerät zur Diagnose des Ermüdungsversagens von Turboladern
DE602006002541D1 (de) Kommunikationsgerät, Kommunikationssystem, und Verfahren zur Einstellung von Kommunikationsparametern des Kommunikationsgeräts
ATE528649T1 (de) Verfahren zum nachweis falsch gefalteter proteine und prionen
ATE496905T1 (de) Triazolyl-pyridyl-benzolsulfonamide als ccr2- oder ccr9-modulatoren zur behandlung von atherosklerose
DE602005004902D1 (de) Künstliches Protein, Verfahren für absolute Quantifizierung der Proteine und seine Benutzung
TW200626899A (en) Frizzled proteins and detection and treatment of cancer
DE602006008581D1 (de) Verfahren zur bestimmung von montagebedingungen, vorrichtung zur bestimmung von montagebedingungen und montagevorrichtung
DE602006017995D1 (de) Verfahren zur herstellung von pregabalin und salzen daraus
WO2007035092A3 (en) Vhh for the diagnosis, prevention and treatment of diseases associated with protein aggregates
DE602006012456D1 (de) Kühlgerät, steuerverfahren für das kühlgerät und verfahren zur bestimmung von anomalien
MY151330A (en) Systems and method for separating proteins from connective tissue
DE602004026912D1 (de) Formulierungen und verfahren zum denaturieren von proteinen
DE602005013650D1 (de) Proteinhydrolysat zur behandlung von müdigkeit
WO2007067512A3 (en) Method for identifying modulators of adprh useful for treating alzheimer's disease
DE602006007421D1 (de) Verfahren und Vorrichtung zur Detektion von Kolloid
DE502006007919D1 (de) Verfahren und vorrichtung zum festwalzen von kurbelwellen
ATE425269T1 (de) Zusammensetzung zur behandlung von leder
DE602006016413D1 (de) Kim-1-antikörper zur behandlung von th2-vermittelten erkrankungen
DE112006002215A5 (de) Proteinzusammensetzung zur Behandlung von Proteinmangelzuständen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition